Your account is not claimed yet. You can sign up with ORCID to claim your account.

Réjean Lapointe (Cécile Grange)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 6

Top Venues

APL bioengineering

Vaccines

Journal of immunology (Baltimore, Md. : 1950)

Science immunology

Institut du Cancer de Montreal

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Institut du Cancer de Montreal Apr 1o 2018

Canada

Scientific director :: Cancer

Publications

Dan Moldoveanu, LeeAnn Ramsay, Mathieu Lajoie, Luke Anderson-Trocme, Marine Lingrand, Diana Berry, Lucas J M Perus, Yuhong Wei, Cleber Moraes, Rached Alkallas, Shivshankari Rajkumar, Dongmei Zuo, Matthew Dankner, Eric Hongbo Xu, Nicholas R Bertos, Hamed S Najafabadi, Simon Gravel, Santiago Costantino, Martin J Richer, Amanda W Lund, Sonia V Del Rincon, Alan Spatz, Wilson H Miller, Rahima Jamal, Réjean Lapointe, Anne-Marie Mes-Masson, Simon Turcotte, Kevin Petrecca, Sinziana Dumitra, Ari-Nareg Meguerditchian, Keith Richardson, Francine Tremblay, Beatrice Wang, May Chergui, Marie-Christine Guiot, Kevin Watters, John Stagg, Abdel Razaq Ahmad A Alyasin, Catalin Mihalcioiu, Sarkis Meterissian
Spatially mapping the immune landscape of melanoma using imaging mass cytometry. Science immunology 7 (70) (2022)
Nicholas Cunningham, Réjean Lapointe, Sophie Lerouge
Biomaterials for enhanced immunotherapy. APL bioengineering 6 (4) (2022)
Nicholas Cunningham, Réjean Lapointe, Sophie Lerouge
Biomaterials for enhanced immunotherapy. APL bioengineering 6 (4) (2022)
David Possamaï, Gabriel Pagé, Rébecca Panes, Etienne Gagnon, Réjean Lapointe
CD40L-Stimulated B Lymphocytes Are Polarized toward APC Functions after Exposure to IL-4 and IL-21. Journal of immunology (Baltimore, Md. : 1950) (2021)
Joanne M Langley, Elodie Pastural, Scott Halperin, Shelly McNeil, May ElSherif, Donna MacKinnon-Cameron, Lingyun Ye, Réjean Lapointe, Valérie Thibodeau, Jean-François Cailhier, Rejean Lapointe, Janet McElhaney, Denis Leclerc, Marilène Bolduc, Marie-Eve Laliberté-Gagné, Denis Leclerc, Pierre Savard
A Randomized Controlled Study to Evaluate the Safety and Reactogenicity of a Novel rVLP-Based Plant Virus Nanoparticle Adjuvant Combined with Seasonal Trivalent Influenza Vaccine Following Single Immunization in Healthy Adults 18-50 Years of Age. Vaccines 8 (3) (2020)
Anne Monette, Derek Bergeron, Amira Ben Amor, Liliane Meunier, Christine Caron, Anne-Marie Mes-Masson, Nidhameddine Kchir, Kamel Hamzaoui, Igor Jurisica, Réjean Lapointe
Immune-enrichment of non-small cell lung cancer baseline biopsies for multiplex profiling define prognostic immune checkpoint combinations for patient stratification. Journal for immunotherapy of cancer 7 (1) (2019)

Réjean Lapointe.css-eqlu8i{font-size:small;padding-left:4px;} (Cécile Grange)

Publication Activity (10 Years)

Top Topics

Top Venues

Réjean Lapointe (Cécile Grange)